Though the below is the official release, the quantum nexus is found here.  The company is nearing finalization of a deal with a to-be-named quantum computing firm.  Through the use of quantum technology, they intend to quickly develop treatment for major depressive disorder for those who are treatment-resistant with the typical pharmaceutical.  From the CrowdFund site:

“We plan to deploy quantum technology to shorten the drug development time, which will give us an advantage over our competitors. With a focus on healing, hope, and compassion, we aim to change the paradigm of mental healthcare with their Psilocybin-based therapies.” 

~ PsiloThera


Because Quantum is Coming.  Qubit

Psychedelic Healthcare Innovation: PsiloThera Announces Launch of Quantum Technology Drug Development Program

“Quantum Technology could ultimately change the way that Humans digest supplements, medications and nutrients.”

PsiloThera’s specialized treatment programs will provide care for Vets, 1st Responders & Patients with Treatment Resistant Mental Illnesses.PsiloThera Logo Framed

PsiloThera CEO, John Atanasio states,”PsiloThera is among the first companies focused on developing novel therapeutics by deploying Quantum Technology that can collect and send materials through organic devices.”

“PsiloThera’s strategy is to have its products lead the future of energy-based nutrients and medication delivery systems.”  “Quantum technology may lead to advances that could ultimately change the way that Humans digest supplements, medications and nutrients.”

“Our Quantum Technology Advisors projects that the technology projects to deliver significant improvements in areas  of Pharmaceutical dispensing issues and adverse effects.”

“Quantum Technology may lead to significant reductions in drug development time and costs, giving PsiloThera a possible major competitive advantage if that were to prove true”

The Journal of American Medical Association- “JAMA PSYCHIATRY” reported in a 2020 study that a treatment of Psilocybin “Magic Mushrooms” works much better than usual anti-depressant medications.

PsiloThera’s outstanding battle tested management team will operate the Company’s  vertical business model  which includes; Fungi Grow, Research & Development, Drug Development, Tele-Mental Health Platform and PsiloThera Treatment Centers.

PsiloThera just launched a Crowdfund Campaign @ 

Source: CISION PR Newswire | Found here...

Content may have been edited for style and clarity.